Department of Integrative Physiology and Neuroscience, Washington State University College of Veterinary Medicine, Pullman, Washington 99164.
Department of Biological Engineering, University of Idaho, Moscow, Idaho 83844.
J Neurosci. 2021 Jan 27;41(4):613-629. doi: 10.1523/JNEUROSCI.1390-20.2020. Epub 2020 Nov 30.
Contextual drug-associated memories precipitate craving and relapse in cocaine users. Such associative memories can be weakened through interference with memory reconsolidation, a process by which memories are maintained following memory retrieval-induced destabilization. We hypothesized that cocaine-memory reconsolidation requires cannabinoid type 1 receptor (CB1R) signaling based on the fundamental role of the endocannabinoid system in synaptic plasticity and emotional memory processing. Using an instrumental model of cocaine relapse, we evaluated whether systemic CB1R antagonism (AM251; 3 mg/kg, i.p.) during memory reconsolidation altered (1) subsequent drug context-induced cocaine-seeking behavior as well as (2) cellular adaptations and (3) excitatory synaptic physiology in the basolateral amygdala (BLA) in male Sprague Dawley rats. Systemic CB1R antagonism, during, but not after, cocaine-memory reconsolidation reduced drug context-induced cocaine-seeking behavior 3 d, but not three weeks, later. CB1R antagonism also inhibited memory retrieval-associated increases in BLA zinc finger 268 (zif268) and activity regulated cytoskeletal-associated protein (Arc) immediate-early gene (IEG) expression and changes in BLA AMPA receptor (AMPAR) and NMDA receptor (NMDAR) subunit phosphorylation that likely contribute to increased receptor membrane trafficking and synaptic plasticity during memory reconsolidation. Furthermore, CB1R antagonism increased memory reconsolidation-associated spontaneous EPSC (sEPSC) frequency in BLA principal neurons during memory reconsolidation. Together, these findings suggest that CB1R signaling modulates cellular and synaptic mechanisms in the BLA that may facilitate cocaine-memory strength by enhancing reconsolidation or synaptic reentry reinforcement, or by inhibiting extinction-memory consolidation. These findings identify the CB1R as a potential therapeutic target for relapse prevention. Drug relapse can be triggered by the retrieval of context-drug memories on re-exposure to a drug-associated environment. Context-drug associative memories become destabilized on retrieval and must be reconsolidated into long-term memory stores to persist. Hence, targeted interference with memory reconsolidation can weaken maladaptive context-drug memories and reduce the propensity for drug relapse. Our findings indicate that cannabinoid type 1 receptor (CB1R) signaling is critical for context-cocaine memory reconsolidation and subsequent drug context-induced reinstatement of cocaine-seeking behavior. Furthermore, cocaine-memory reconsolidation is associated with CB1R-dependent immediate-early gene (IEG) expression and changes in excitatory synaptic proteins and physiology in the basolateral amygdala (BLA). Together, our findings provide initial support for CB1R as a potential therapeutic target for relapse prevention.
语境药物关联记忆会促使可卡因使用者产生渴望和复吸。通过干扰记忆再巩固,可以削弱这种关联记忆,记忆再巩固是指在记忆检索引起的不稳定性后,记忆得以维持的过程。我们假设可卡因记忆再巩固需要大麻素 1 型受体(CB1R)信号,这是基于内源性大麻素系统在突触可塑性和情绪记忆处理中的基本作用。我们使用可卡因复吸的工具模型来评估,在记忆再巩固期间,全身性 CB1R 拮抗(AM251;3mg/kg,ip)是否会改变(1)随后的药物环境引发的可卡因寻求行为,以及(2)细胞适应和(3)在雄性 Sprague Dawley 大鼠的外侧杏仁核(BLA)中的兴奋性突触生理学。在可卡因记忆再巩固期间而不是之后,全身性 CB1R 拮抗作用降低了 3 天后但不是 3 周后药物环境引发的可卡因寻求行为。CB1R 拮抗作用还抑制了记忆检索相关的 BLA 锌指 268(zif268)和活性调节细胞骨架相关蛋白(Arc)即时早期基因(IEG)表达的增加,以及 BLA AMPA 受体(AMPAR)和 NMDA 受体(NMDAR)亚基磷酸化的变化,这些变化可能导致记忆再巩固期间受体膜转运和突触可塑性增加。此外,CB1R 拮抗作用增加了记忆再巩固期间 BLA 主神经元中记忆再巩固相关的自发 EPSC(sEPSC)频率。总之,这些发现表明,CB1R 信号调节 BLA 中的细胞和突触机制,通过增强再巩固或突触再进入强化,或通过抑制消退-记忆巩固,可能促进可卡因记忆强度。这些发现确定了 CB1R 作为预防复发的潜在治疗靶点。药物复吸可以通过重新暴露于与药物相关的环境中检索与药物相关的记忆而引发。与药物相关的语境关联记忆在检索后变得不稳定,必须重新巩固到长期记忆库中才能持续存在。因此,有针对性地干扰记忆再巩固可以削弱适应不良的与药物相关的记忆,并降低药物复吸的倾向。我们的发现表明,大麻素 1 型受体(CB1R)信号对于语境可卡因记忆再巩固和随后的药物环境引发的可卡因寻求行为的恢复至关重要。此外,可卡因记忆再巩固与 CB1R 依赖性即时早期基因(IEG)表达以及外侧杏仁核(BLA)中兴奋性突触蛋白和生理学的变化有关。总之,我们的研究结果初步支持 CB1R 作为预防复发的潜在治疗靶点。